MDMikail Dağ

Mikail Dağ

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikail Dağ has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The frequency of irritable bowel syndrome in predialysis patients with chronic kidney disease and its associated factors

    by Edip Erkuş, İbRahim Güney, Şeyma Kahyaoğlu, Mikail Dağ, Yasin Taşdelen, Fatih Ergül

    Aim: This study aimed to determine the frequency of irritable bowel syndrome (IBS) and associated factors, as well as the levels of depression and anxiety, in patients with chronic kidney disease (CKD) not receiving dialysis. It also aimed to explore potential measures to improve quality of life.Materials and Methods: Patients with stage III–V predialysis CKD were assessed for IBS based on the Rome IV criteria. Anxiety and depression levels were evaluated using the Hamilton Anxiety and Depression Rating Scales. Patients were divided into two groups based on the presence of IBS.Results: Among 154 patients, 33 (21.4%) had IBS and 121 (78.6%) did not. In the IBS group, 5 patients had no anxiety, 14 had mild, and 14 had major anxiety. In the non-IBS group, 44 had no anxiety, 52 had mild, and 25 had major anxiety. A significant difference in anxiety levels was observed between the two groups, but no significant difference was found in depression levels. Subgroup analysis also revealed a significant difference in anxiety. While no significant differences were found regarding the use of phosphate binders, calcium channel blockers, or beta-blockers, ACE inhibitor/ARB use was significantly higher in the IBS group.Conclusion: IBS was more frequent in predialysis CKD patients compared to the general population. Anxiety was more common in IBS patients, and ACEI/ARB use was associated with increased IBS frequency. IBS can begin before dialysis, so it should be considered when managing treatment in predialysis CKD patients.

  • Open Access

    Effect of iron sucrose on intradialytic blood pressure in patients receiving maintenance hemodialysis treatment

    by Fatih Ergül, Beyza Doğan, Mikail Dağ, Süleyman Karaköse, İbRahim Güney

    Aims: There are studies showing that IV iron sucrose is vasoactive and causes changes in intradialytic blood pressure in hemodialysis patients. Intradialytic hypotension has been associated with vascular thrombosis, inadequate dialysis, and increased mortality. Intradialytic hypertension, has been shown in some studies to be associated with increased cardiovascular mortality and an increase in the frequency of hospitalization. In this study, we aimed to investigate the effect of iron sucrose on intradialytic blood pressure in hemodialysis patients.Methods: In this study, 59 patients undergoing hemodialysis three times a week had their blood pressure measured before hemodialysis and recorded at minute 0. 100 mg/5 ml iron sucrose was administered as an IV infusion during the first 30 minutes of dialysis treatment, and blood pressure was measured and recorded every 30 minutes. The same patient's blood pressure was measured every 30 minutes during the next hemodialysis session without iron sucrose treatment. Results: Intradialytic hypotension developed in two different patient; one patient in the session in which iron sucrose was given and one in the session in which iron sucrose was not given. There was no significant difference in intradialytic hypertension between the groups according to all three definitions of intradialytic hypertension (p=0.134; 0.523; and 1, respectively).Conclusion: We found that iron sucrose administration does not cause both intradialytic hypotension and intradialytic hypertension.

  • Open Access

    The Relationship Between Mucociliary Clearance Time and Peritonitis Frequency in Patients Receiving Peritoneal Dialysis

    by Beyza Doğan, Fatih Ergül, Ramazan Basut, Süleyman Karaköse, Abitter Yücel, Mikail Dağ, İbRahim Güney

    Background: The present study sought to explore the association between nasal mucociliary clearance time (MCT) and the frequency of peritonitis among patients with chronic kidney disease (CKD) treated by peritoneal dialysis (PD). Methods: This cross-sectional study enrolled 24 patients with CKD treated by PD and 24 healthy volunteers. Nasal muco ciliary function was assessed using the saccharin transit time test. In this procedure, a saccharin particle with a 1 mm diameter was meticulously placed on the anteromedial surface of the inferior nasal concha. The 2 groups were compared based on their mean MCT. Within the patient group, the number of peritonitis cases in the last year was evaluated, and the correlation between MCT and the occurrence of peritonitis was analyzed. Results: The patient group consisted of 15 females and 9 males, with a mean age of 52.6 years. The control group included 14 females and 10 males, with a mean age of 47.5 years. The mean duration of PD among the followed cohort was 20 months, ranging from 3 to 190 months. The comparison of mean MCT between patients with a history of peritonitis and those with out peritonitis did not reveal a statistically significant difference (P = .333). However, the neutrophil-to-lymphocyte ratio was significantly elevated in the group exhibiting prolonged MCT (P = .046). Conclusion: Although this study found no statistically significant direct relationship between peritonitis incidence and MCT, the research aimed to evaluate MCT as a potential indicator of susceptibility to respiratory tract infections, which play a role in the development of peritonitis. Cite this article as: Doğan B, Ergül F, Basut R, et al. The relationship between mucociliary clearance time and peritonitis frequency in patients receiving peritoneal dialysis. Turk J Nephrol. 2026;35(1):67-71.

  • Assessing ciliary function in polycystic kidney disease: beyond the kidney

    by Beyza Doğan, Fatih Ergül, Mikail Dağ, Süleyman Karaköse, Latif Emre Özdemir, Abitter Yücel, İbRahim Güney

    This study sought to investigate the effects of polycystic kidney disease and tolvaptan administration on mucociliary clearance. The cross-sectional study enrolled 30 patients with autosomal dominant polycystic kidney disease undergoing tolvaptan therapy, 30 patients with autosomal dominant polycystic kidney disease not on tolvaptan, and 30 healthy volunteers. Nasal mucociliary clearance time was determined using the saccharin transit time test, with a 1 mm diameter saccharin particle carefully placed on the anteromedial surface of the inferior nasal concha. Comparisons of mucociliary clearance time were then performed between the groups. In our study, the average mucociliary clearance time for patients with polycystic kidney disease was determined to be 9, in contrast to an average of 11 in the control group. A comparative analysis of patients receiving tolvaptan and those not receiving tolvaptan revealed an identical average mucociliary clearance time of 9 for both cohorts (p = 0.706). Furthermore, patients treated with tolvaptan demonstrated an average urine specific gravity of 1004, significantly lower than the 1011 observed in the non-tolvaptan group (p = 0.001). This study indicates that the administration of tolvaptan yielded a beneficial impact on hydration status; however, this improved hydration did not translate into a significant effect on mucociliary clearance. Furthermore, the mucociliary clearance times recorded in the patient group were found to be in alignment with those typically associated with chronic kidney disease cohorts.


  • Open Access

    Evaluation of patients admitted to the hematology outpatient clinic for spontaneous ecchymosis: Does it suggest bleeding diathesis?

    by Seda Yilmaz, Rafiye Ci̇fTci̇lEr, Mikail Dağ

    Background: Spontaneous ecchymosis is a common reason for referral to the hematology outpatient clinic. It is important to determine whether the underlying bleeding is benign or a symptom of diathesis. Methods: The sample of this retrospective study consisted of 119 patients with normal platelet counts who presented to the adult hematology outpatient clinic with spontaneous ecchymosis between September 2021 and August 2022. The site of the ecchymosis, patients’ familial and bleeding histories, and the drugs they have been using were queried. Hemogram and coagulation parameters and peripheral smear findings of the patients were recorded, and their ISTH-SSC (International Society on Thrombosis and Haemostasis Scientific and Standardization Committee) Bleeding Assessment Tool scores were calculated. Results: The median age of the patients, of whom 113 (95%) were female and 6 (5%) were male, was 30 (18-85) years. The ecchymosis was in the extremities and the trunk in 110 (92.4%) and 9 (7.6%) patients, respectively. There was no significant difference between the patients with and without bleeding history in terms of the site of spontaneous ecchymosis, the hemogram parameters and peripheral smear findings. Similarly, the patients with and without factor deficiency have not differed significantly in terms of hemogram parameters and peripheral smear findings. Patients with any factor deficiency had significantly higher ISTH-SSC Bleeding Assessment Tool scores compared to the patients without factor deficiency. Conclusion: The findings of the study revealed that the site of ecchymosis and hemogram and coagulation parameters cannot be used as markers in the general sense, except for the ISTH-SSC Bleeding Assessment Tool scores, which predicted factor deficiency. Another finding of the study worth mentioning is the fact that number of patients with ecchymosis on the trunk among the patients presenting with the complaint of ecchymosis was significantly lower than that of patients with ecchymosis on the extremities.

  • Open Access

    The Importance of neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, and thrombocyte-lymphocyte ratio in addition to abnormal laboratory parameters in COVID-19 pneumonia

    by Nermin Keni̇ Begendi̇, Fatma Kaçar, Mikail Dağ, Arzu Tarakçi, Şule Özdemi̇r Armağan, Fatih Saçkan, Muhammet Cemal Kizilarslanoğlu

    Aim: We aimed to examine the importance of the neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR) and thrombocyte-lymphocyte ratio (TLR) in addition to laboratory parameters in terms of pneumonia between patients with and without pneumonia diagnosed with COVID-19 infection. Materials and Methods: In our retrospective study, 506 patients diagnosed with COVID-19 who were hospitalized and treated between April 2020 and July 2020 were included. While 50.6% (n= 256) of the patients had pneumonia, 49.4% (n= 250) did not have. File informations were scanned; the demographic data, hospitalization and discharge laboratory parameters were recorded. Results: The median age of the patients was 44.5 (16-89) years, 55.5% (n= 281) of them were male. The median age of patients with pneumonia was higher than those without pneumonia, and the frequency of female gender was higher (p <0.05 for both conditions). The lymphocyte count at hospitalization and discharge was significantly lower in patients with pneumonia (p <0.001, 0.007, respectively). The count of eosinophils at hospitalization was significantly lower in patients with pneumonia (p <0.001). NLR and TLR values were significantly higher in patients with pneumonia at admission and discharge (p <0.008, <0.007, respectively for NLR and p <0.001, p<0.001 respectively for TLR). MLR values at discharge were higher in patients with pneumonia (p = 0.001). In ROC analyzes made in terms of predicting pneumonia; hospitalization CRP level, eosinophil, monocyte counts and TLR values were found to be important variables. Conclusion: In this study, the importance of monocyte, eosinophil counts and TLR values in COVID-19 pneumonia was demonstrated. Amaç: COVID-19 pnömonisi olan ve olmayan hastalar arasındaki klinik ve hematolojik parametrelerdeki farklılıkların irdelenmesi, yatış ve taburculuk değerlerinin kıyaslanması, laboratuvar parametrelerinin yanında nötrofil-lenfosit oranı (NLO), monosit-lenfosit oranı (MLO) ve trombosit-lenfosit oranı (TLO)’ nın pnömoni açısından öneminin karşılaştırılması amaçlandı. Gereç ve Yöntem: Retrospektif yaptığımız çalışmada Enfeksiyon Hastalıkları servisinde Nisan 2020-Temmuz 2020 tarihleri arasında yatarak tedavi alan COVID-19 tanılı 506 hasta dahil edildi. Hastaların 256’sı pnömoni tablosu olan (%50,6), 250’si pnömoni tablosu olmayan (%49,4) COVID-19 tanılı olgular idi. Her iki hasta grubunda dosya bilgileri taranarak demografik veriler, yatış ve taburculuklarındaki laboratuvar parametreleri, NLO, MLO ve TLO irdelenip karşılaştırıldı. Bulgular: Hastaların medyan yaşı 44,5 (16-89) yıl olup, %55,5 (n= 281)’i erkek idi. Pnömonisi olan hastaların medyan yaşı pnömonisi olmayanlara göre daha yüksekti ve bu grupta kadın cinsiyet sıklığının daha fazla olduğu görüldü (her iki durumda p<0,05). Pnömonisi olanların hastanede ortanca kalış süresi pnömoni olmayanlara göre daha yüksekti (p:0,009). Pnömonisi olanlarda olmayanlara göre yatış ve taburculuk lenfosit sayısı anlamlı olarak daha düşük idi (p değeri sırasıyla: <0,001, 0,007). Pnömonisi olanlarda olmayanlara göre yatış eozinofil sayısı anlamlı olarak daha düşük gözlendi (p<0,001). Pnömonisi olan hastaların yatış ve taburculuk NLO pnömonisi olmayan hastalara göre anlamlı olarak daha yüksek gözlendi (p sırasıyla <0,008, <0,007). Her iki grupta taburculuk NLO değeri yatış değerine göre düşük saptandı (her iki durumda p; <0.001). TLO pnömonisi olanlarda olmayanlara göre hem yatış hem de taburculukta daha yüksek görüldü (her iki durumda p 105,7 olmasının AUC:0,611, %75,4 sensitivite, %46,0 spesifiteye sahip olduğu gözlendi. Sonuç: Bu çalışmada özellikle monosit, eozinofil sayıları ve TLO oranlarının COVID-19 pnömonisindeki önemi gösterilmiş oldu.